Loading...
Back to narrative

524370: Future Returns Will Benefit From Stable Margins And Modest Multiple Expansion

Update shared on 06 Dec 2025

n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
-25.9%
7D
1.0%

Analysts have nudged their price target on Bodal Chemicals slightly higher to ₹107.0 per share from ₹107, reflecting a marginally increased discount rate and modestly higher expectations for the company’s future valuation multiples while keeping growth and margin assumptions broadly unchanged.

What's in the News

  • A board meeting is scheduled for November 12, 2025 to consider and approve standalone and consolidated unaudited financial results for the quarter and half year ended September 30, 2025, and to take up any other business (Key Developments).
  • Shareholders at the September 26, 2025 AGM approved the appointment of M/s. BNP Sand Associates LLP as Statutory Auditor following the merger of M/s. Naresh J, Patel & Co. (Key Developments).

Valuation Changes

  • Fair Value: Maintained essentially flat at around ₹107.0 per share, indicating no material change in intrinsic value estimates.
  • Discount Rate: Risen slightly from about 16.90 percent to 17.10 percent, reflecting a marginally higher perceived risk or required return.
  • Revenue Growth: Kept broadly unchanged at roughly 13.80 percent, suggesting stable expectations for top line expansion.
  • Net Profit Margin: Held steady at about 6.23 percent, implying no significant revision to long term profitability assumptions.
  • Future P/E: Increased slightly from around 13.47x to 13.54x, indicating a modestly higher valuation multiple applied to projected earnings.

Have other thoughts on Bodal Chemicals?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.